The vitamin D questions: How much do you need and how should you get it?

Published:January 04, 2006DOI:https://doi.org/10.1016/j.jaad.2005.11.1057
      UV radiation is a well-documented human carcinogen, indisputably linked to the current continued increased rate of skin cancer. UV radiation is also responsible for cutaneous synthesis of vitamin (vit) D 3, a substance that is then sequentially hydroxylated in the liver and kidney to yield 1,25(OH) 2 vit D, a hormone critical for calcium homeostasis and skeletal maintenance. Because the UV action spectra for DNA damage leading to skin cancer and for vit D photosynthesis are virtually identical, the harmful and beneficial effects of UV irradiation are inseparable. This has given rise to the argument that sun avoidance, with a goal of skin cancer prevention, may compromise vit D sufficiency. Public interest in this matter has been heightened in recent years by multiple studies correlating the level of 25-OH vit D, the readily measurable “storage” precursor form of the vit, with a variety of benefits separate from skeletal health. Although the studies are of variable quality and all alleged treatment benefits are based on dietary supplementation with vit D, not on increased sun exposure, they have been interpreted by some as support for advocating increased sun exposure of the public at large. The goal of this review is to provide a detailed, balanced, and referenced discussion of the complex literature underlying the current popular interest in vit D and sun exposure for the purpose of increasing vit D photosynthesis. We review the nomenclature, metabolism, and established functions of vit D; the evidence supporting the less well-established but purported vit D effects; the concept of vit D insufficiency; populations at risk for vit D deficiency; and finally the risk/benefit of obtaining vit D from cutaneous photosynthesis versus diet or supplementation.

      Abbreviations used:

      DHC ( dehydrocholesterol), DM ( diabetes mellitus), FDA ( Food and Drug Administration), GI ( gastrointestinal), PTH ( parathyroid hormone), RDA ( recommended daily allowance), SPF ( sun protection factor), VDR ( vitamin D receptor), vit ( vitamin)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gilchrest B.
        Anti-sunshine vitamin A.
        Nat Med. 1999; 5: 376-377
        • Welch T.R.
        • Bergstrom W.H.
        • Tsang R.C.
        Vitamin D–deficient rickets: the reemergence of a once-conquered disease.
        J Pediatr. 2000; 137: 143-145
        • Albert M.R.
        • Ostheimer K.G.
        The evolution of current medical and popular attitudes toward ultraviolet light exposure: part 3.
        J Am Acad Dermatol. 2003; 49: 1096-1106
        • Poochareon V.N.
        • Cockerell C.J.
        The war against skin cancer: the time for action is now.
        Arch Dermatol. 2005; 141: 499-501
        • Rigel D.S.
        Photoprotection: a 21st century perspective.
        Br J Dermatol. 2002; 146: 34-37
        • Yaar M.
        • Eller M.S.
        • Gilchrest B.A.
        Fifty years of skin aging.
        J Investig Dermatol Symp Proc. 2002; 7: 51-58
        • Fry A.
        • Verne J.
        Preventing skin cancer.
        BMJ. 2003; 326: 114-115
        • Young A.R.
        Tanning devices–fast track to skin cancer?.
        Pigment Cell Res. 2004; 17: 2-9
        • Holick M.F.
        Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications.
        in: Favus M. Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams and Wilkins, Philadelphia1999: 92-98
        • Holick M.F.
        The use and interpretation of assays for vitamin D and its metabolites.
        J Nutr. 1990; 120: 1464-1469
        • Vieth R.
        Why “vitamin D” is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids.
        J Steroid Biochem Mol Biol. 2004; 89-90: 571-573
        • Holick M.F.
        The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system.
        J Invest Dermatol. 1981; 77: 51-58
        • Holick M.F.
        • MacLaughlin J.A.
        • Clark M.B.
        • Holick S.A.
        • Potts Jr., J.T.
        • Anderson R.R.
        • et al.
        Photosynthesis of previtamin D3 in human skin and the physiologic consequences.
        Science. 1980; 210: 203-205
        • MacLaughlin J.A.
        • Anderson R.R.
        • Holick M.F.
        Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin.
        Science. 1982; 216: 1001-1003
        • Holick M.F.
        The UV advantage.
        ibooks Inc, New York2004 (p. 224)
        • Rapuri P.B.
        • Gallagher J.C.
        • Haynatzki G.
        Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter.
        Calcif Tissue Int. 2004; 74: 150-156
        • Rapuri P.B.
        • Gallagher J.C.
        Effect of vitamin D supplement use on serum concentrations of total 25OHD levels in elderly women.
        J Steroid Biochem Mol Biol. 2004; 89-90: 601-604
        • Trang H.M.
        • Cole D.E.
        • Rubin L.A.
        • Pierratos A.
        • Siu S.
        • Vieth R.
        Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.
        Am J Clin Nutr. 1998; 68: 854-858
        • Armas L.A.
        • Hollis B.W.
        • Heaney R.P.
        Vitamin D2 is much less effective than vitamin D3 in humans.
        J Clin Endocrinol Metab. 2004; 89: 5387-5391
        • Holick M.F.
        Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health.
        Curr Opin Endocrinol Diabetes. 2002; 9: 87-98
        • Shoback D.M.R.
        • Bikle D.
        Metabolic bone disease.
        in: Greenspan F.S.A.G. David G. Basic and clinical endocrinology. Lange Medical Books/McGraw-Hill, New York2004: 322
        • Klein G.
        Nutritional rickets and osteomalacia.
        in: Favus M. Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams and Wilkins, Philadelphia1999: 315-319
        • Pfeifer M.
        • Begerow B.
        • Minne H.W.
        Vitamin D and muscle function.
        Osteoporos Int. 2002; 13: 187-194
        • Plotnikoff G.A.
        • Quigley J.M.
        Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain.
        Mayo Clin Proc. 2003; 78: 1463-1470
        • Vieth R.
        Vitamin D supplementation 25-hydroxyvitamin D concentrations, and safety.
        Am J Clin Nutr. 1999; 69: 842-856
        • Adams J.S.
        • Clemens T.L.
        • Parrish J.A.
        • Holick M.F.
        Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects.
        N Engl J Med. 1982; 306: 722-725
        • Reichel H.
        • Koeffler H.P.
        • Norman A.W.
        The role of the vitamin D endocrine system in health and disease.
        N Engl J Med. 1989; 320: 980-991
        • Weaver C.M.
        • Fleet J.C.
        Vitamin D requirements: current and future.
        Am J Clin Nutr. 2004; 80: 1735S-1739S
        • Hollis B.W.
        Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.
        J Nutr. 2005; 135: 317-322
        • Vieth R.
        Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults.
        J Steroid Biochem Mol Biol. 2004; 89-90: 575-579
        • Dawson-Hughes B.
        • Harris S.S.
        • Dallal G.E.
        Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women.
        Am J Clin Nutr. 1997; 65: 67-71
        • Gloth III, F.M.
        • Gundberg C.M.
        • Hollis B.W.
        • Haddad Jr., J.G.
        • Tobin J.D.
        Vitamin D deficiency in homebound elderly persons.
        JAMA. 1995; 274: 1683-1686
        • Kinyamu H.K.
        • Gallagher J.C.
        • Rafferty K.A.
        • Balhorn K.E.
        Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites.
        Am J Clin Nutr. 1998; 67: 342-348
        • Malabanan A.
        • Veronikis I.E.
        • Holick M.F.
        Redefining vitamin D insufficiency.
        Lancet. 1998; 351: 805-806
        • Ooms M.E.
        • Lips P.
        • Roos J.C.
        • van der Vijgh W.J.
        • Popp-Snijders C.
        • Bezemer P.D.
        • et al.
        Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
        J Bone Miner Res. 1995; 10: 1177-1184
        • Thomas M.K.
        • Lloyd-Jones D.M.
        • Thadhani R.I.
        • Shaw A.C.
        • Deraska D.J.
        • Kitch B.T.
        • et al.
        Hypovitaminosis D in medical inpatients.
        N Engl J Med. 1998; 338: 777-783
        • Okonofua F.
        • Gill D.S.
        • Alabi Z.O.
        • Thomas M.
        • Bell J.L.
        • Dandona P.
        Rickets in Nigerian children: a consequence of calcium malnutrition.
        Metabolism. 1991; 40: 209-213
        • Holick M.F.
        In reply to “Vitamin D deficiency and chronic pain: cause and effect or epiphenomenon?”.
        Mayo Clin Proc. 2004; 79: 699
        • Holick M.F.
        Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.
        Am J Clin Nutr. 2004; 79: 362-371
        • Nesby-O'Dell S.
        • Scanlon K.S.
        • Cogswell M.E.
        • Gillespie C.
        • Hollis B.W.
        • Looker A.C.
        • et al.
        Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third national health and nutrition examination survey, 1988-1994.
        Am J Clin Nutr. 2002; 76: 187-192
        • Parfitt A.M.
        • Gallagher J.C.
        • Heaney R.P.
        • Johnston C.C.
        • Neer R.
        • Whedon G.D.
        Vitamin D and bone health in the elderly.
        Am J Clin Nutr. 1982; 36: 1014-1031
        • Tangpricha V.
        • Pearce E.N.
        • Chen T.C.
        • Holick M.F.
        Vitamin D insufficiency among free-living healthy young adults.
        Am J Med. 2002; 112: 659-662
        • Heaney R.P.
        Lessons for nutritional science from vitamin D.
        Am J Clin Nutr. 1999; 69: 825-826
        • van der Wielen R.P.
        • Lowik M.R.
        • van den Berg H.
        • de Groot L.C.
        • Haller J.
        • Moreiras O.
        • et al.
        Serum vitamin D concentrations among elderly people in Europe.
        Lancet. 1995; 346: 207-210
        • Dawson-Hughes B.
        • Dallal G.E.
        • Krall E.A.
        • Harris S.
        • Sokoll L.J.
        • Falconer G.
        Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women.
        Ann Intern Med. 1991; 115: 505-512
        • Dawson-Hughes B.
        • Harris S.S.
        • Krall E.A.
        • Dallal G.E.
        • Falconer G.
        • Green C.L.
        Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D.
        Am J Clin Nutr. 1995; 61: 1140-1145
        • Dawson-Hughes B.
        • Harris S.S.
        • Krall E.A.
        • Dallal G.E.
        Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
        N Engl J Med. 1997; 337: 670-676
        • Feskanich D.
        • Willett W.C.
        • Colditz G.A.
        Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women.
        Am J Clin Nutr. 2003; 77: 504-511
        • Michaelsson K.
        • Melhus H.
        • Bellocco R.
        • Wolk A.
        Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk.
        Bone. 2003; 32: 694-703
        • Chapuy M.C.
        • Arlot M.E.
        • Delmas P.D.
        • Meunier P.J.
        Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women.
        BMJ. 1994; 308: 1081-1082
        • Chapuy M.C.
        • Arlot M.E.
        • Duboeuf F.
        • Brun J.
        • Crouzet B.
        • Arnaud S.
        • et al.
        Vitamin D3 and calcium to prevent hip fractures in the elderly women.
        N Engl J Med. 1992; 327: 1637-1642
        • Chapuy M.C.
        • Meunier P.J.
        Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements.
        Osteoporos Int. 1996; 6: 60-63
        • Chapuy M.C.
        • Pamphile R.
        • Paris E.
        • Kempf C.
        • Schlichting M.
        • Arnaud S.
        • et al.
        Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study.
        Osteoporos Int. 2002; 13: 257-264
        • Gallagher J.C.
        The effects of calcitriol on falls and fractures and physical performance tests.
        J Steroid Biochem Mol Biol. 2004; 89-90: 497-501
        • Heikinheimo R.J.
        • Inkovaara J.A.
        • Harju E.J.
        • Haavisto M.V.
        • Kaarela R.H.
        • Kataja J.M.
        • et al.
        Annual injection of vitamin D and fractures of aged bones.
        Calcif Tissue Int. 1992; 51: 105-110
        • Lips P.
        • Graafmans W.C.
        • Ooms M.E.
        • Bezemer P.D.
        • Bouter L.M.
        Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial.
        Ann Intern Med. 1996; 124: 400-406
        • Meyer H.E.
        • Smedshaug G.B.
        • Kvaavik E.
        • Falch J.A.
        • Tverdal A.
        • Pedersen J.I.
        Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial.
        J Bone Miner Res. 2002; 17: 709-715
        • Trivedi D.P.
        • Doll R.
        • Khaw K.T.
        Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial.
        BMJ. 2003; 326: 469
        • Grant A.M.
        • Avenell A.
        • Campbell M.K.
        • McDonald A.M.
        • MacLennan G.S.
        • McPherson G.C.
        • et al.
        Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomized evaluation of calcium or vitamin D, RECORD): a randomized placebo-controlled trial.
        Lancet. 2005; 365: 1621-1628
        • Porthouse J.
        • Cockayne S.
        • King C.
        • Saxon L.
        • Steele E.
        • Aspray T.
        • et al.
        Randomized controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care.
        BMJ. 2005; 330: 1003
        • Bischoff-Ferrari H.A.
        • Willett W.C.
        • Wong J.B.
        • Giovannucci E.
        • Dietrich T.
        • Dawson-Hughes B.
        Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.
        JAMA. 2005; 293: 2257-2264
        • Lips P.
        • Wiersinga A.
        • van Ginkel F.C.
        • Jongen M.J.
        • Netelenbos J.C.
        • Hackeng W.H.
        • et al.
        The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.
        J Clin Endocrinol Metab. 1988; 67: 644-650
        • Ooms M.E.
        • Roos J.C.
        • Bezemer P.D.
        • van der Vijgh W.J.
        • Bouter L.M.
        • Lips P.
        Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.
        J Clin Endocrinol Metab. 1995; 80: 1052-1058
        • Sambrook P.
        Vitamin D and fractures: quo vadis?.
        Lancet. 2005; 365: 1599-1600
        • Lamprecht S.A.
        • Lipkin M.
        Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms.
        Nat Rev Cancer. 2003; 3: 601-614
        • Stumpf W.E.
        • Sar M.
        • Reid F.A.
        • Tanaka Y.
        • DeLuca H.F.
        Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.
        Science. 1979; 206: 1188-1190
        • Bischoff-Ferrari H.A.
        • Borchers M.
        • Gudat F.
        • Durmuller U.
        • Stahelin H.B.
        • Dick W.
        Vitamin D receptor expression in human muscle tissue decreases with age.
        J Bone Miner Res. 2004; 19: 265-269
        • van de Kerkhof P.C.
        Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms.
        Br J Dermatol. 1995; 132: 675-682
        • Smith E.L.
        • Walworth N.C.
        • Holick M.F.
        Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.
        J Invest Dermatol. 1986; 86: 709-714
        • Bikle D.D.
        Vitamin D regulated keratinocyte differentiation.
        J Cell Biochem. 2004; 92: 436-444
        • Kragballe K.
        Treatment of psoriasis with calcipotriol and other vitamin D analogues.
        J Am Acad Dermatol. 1992; 27: 1001-1008
        • van de Kerkhof P.C.
        An update on vitamin D3 analogues in the treatment of psoriasis.
        Skin Pharmacol Appl Skin Physiol. 1998; 11: 2-10
        • Glerup H.
        • Mikkelsen K.
        • Poulsen L.
        • Hass E.
        • Overbeck S.
        • Andersen H.
        • et al.
        Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement.
        Calcif Tissue Int. 2000; 66: 419-424
        • Bischoff-Ferrari H.A.
        • Dawson-Hughes B.
        • Willett W.C.
        • Staehelin H.B.
        • Bazemore M.G.
        • Zee R.Y.
        • et al.
        Effect of vitamin D on falls: a meta-analysis.
        JAMA. 2004; 291: 1999-2006
        • Garland C.F.
        • Garland F.C.
        • Gorham E.D.
        Can colon cancer incidence and death rates be reduced with calcium and vitamin D?.
        Am J Clin Nutr. 1991; 54: 193S-201S
        • Garland C.F.
        More on preventing skin cancer: sun avoidance will increase incidence of cancers overall.
        BMJ. 2003; 327: 1228
      1. Garland CF. Sun avoidance will increase overall cancer incidence. Available at: http://bmj.bmjjournals.com/cgi/eletters/326/7381/114#28926. Accessed January 19, 2003.

        • Garland C.F.
        • Garland F.C.
        • Gorham E.D.
        Calcium and vitamin D. Their potential roles in colon and breast cancer prevention.
        Ann N Y Acad Sci. 1999; 889: 107-119
      2. Grant WB. The benefits of sunlight outweigh the harms. Available at: http://bmj.bmjjournals.com/cgi/eletters/326/7381/114#28926. Accessed January 18, 2003.

        • Grant W.B.
        • Garland C.F.
        Evidence supporting the role of vitamin D in reducing the risk of cancer.
        J Intern Med. 2002; 252: 178-180
        • Grau M.V.
        • Baron J.A.
        • Sandler R.S.
        • Haile R.W.
        • Beach M.L.
        • Church T.R.
        • et al.
        Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.
        J Natl Cancer Inst. 2003; 95: 1765-1771
        • Tuohimaa P.
        • Tenkanen L.
        • Ahonen M.
        • Lumme S.
        • Jellum E.
        • Hallmans G.
        • et al.
        Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
        Int J Cancer. 2004; 108: 104-108
        • McMichael A.J.
        • Hall A.J.
        Multiple sclerosis and ultraviolet radiation: time to shed more light.
        Neuroepidemiology. 2001; 20: 165-167
        • Gross M.D.
        Vitamin D and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs.
        J Nutr. 2005; 135: 326-331
        • Hartman T.J.
        • Albert P.S.
        • Snyder K.
        • Slattery M.L.
        • Caan B.
        • Paskett E.
        • et al.
        The association of calcium and vitamin D with risk of colorectal adenomas.
        J Nutr. 2005; 135: 252-259
        • Majewski S.
        • Skopinska M.
        • Marczak M.
        • Szmurlo A.
        • Bollag W.
        • Jablonska S.
        Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis.
        J Investig Dermatol Symp Proc. 1996; 1: 97-101
        • Mehta R.G.
        • Mehta R.R.
        Vitamin D and cancer.
        J Nutr Biochem. 2002; 13: 252-264
        • Tamimi R.M.
        • Lagiou P.
        • Adami H.-O.
        • Trichopoulos D.
        Comments on “Evidence supporting the role of vitamin D in reducing the risk of cancer”.
        J Intern Med. 2002; 252: 179-180
        • Goodman G.E.
        • Thornquist M.D.
        • Balmes J.
        • Cullen M.R.
        • Meyskens Jr., F.L.
        • Omenn G.S.
        • et al.
        The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
        J Natl Cancer Inst. 2004; 96: 1743-1750
        • Hennekens C.H.
        • Buring J.E.
        • Manson J.E.
        • Stampfer M.
        • Rosner B.
        • Cook N.R.
        • et al.
        Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
        N Engl J Med. 1996; 334: 1145-1149
        • Lee I.M.
        • Cook N.R.
        • Manson J.E.
        • Buring J.E.
        • Hennekens C.H.
        Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the women's health study.
        J Natl Cancer Inst. 1999; 91: 2102-2106
        • Vanchieri C.
        Studies shedding light on vitamin D and cancer.
        J Natl Cancer Inst. 2004; 96: 735-736
        • Deluca H.F.
        • Cantorna M.T.
        Vitamin D: its role and uses in immunology.
        FASEB J. 2001; 15: 2579-2585
        • Ponsonby A.L.
        • McMichael A.
        • van der Mei I.
        Ultraviolet radiation and autoimmune disease: insights from epidemiological research.
        Toxicology. 2002; 181-182: 71-78
        • Adorini L.
        Intervention in autoimmunity: the potential of vitamin D receptor agonists.
        Cell Immunol. 2005; 233: 115-124
        • Cantorna M.T.
        • Mahon B.D.
        Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.
        Exp Biol Med. 2004; 229: 1136-1142
        • Hypponen E.
        Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide.
        Nutr Rev. 2004; 62: 340-347
        • The EURODIAB Substudy 2 Study Group
        Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus.
        Diabetologia. 1999; 42: 51-54
        • Stene L.C.
        • Joner G.
        Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study.
        Am J Clin Nutr. 2003; 78: 1128-1134
        • Harris S.S.
        Vitamin D in type 1 diabetes prevention.
        J Nutr. 2005; 135: 323-325
        • Hypponen E.
        • Laara E.
        • Reunanen A.
        • Jarvelin M.R.
        • Virtanen S.M.
        Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.
        Lancet. 2001; 358: 1500-1503
        • Goldberg P.
        • Fleming M.C.
        • Picard E.H.
        Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.
        Med Hypotheses. 1986; 21: 193-200
        • Nordvik I.
        • Myhr K.M.
        • Nyland H.
        • Bjerve K.S.
        Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.
        Acta Neurol Scand. 2000; 102: 143-149
        • Ponsonby A.L.
        • Lucas R.M.
        • van der Mei I.A.
        A potential role for UVR and vitamin D in the induction of multiple sclerosis, type 1 diabetes, rheumatoid arthritis.
        Photochem Photobiol. 2005; (Available at:) (. Accessed June 21, 2005)
      3. Risks and benefits of sun exposure position statement: approved by the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia, Australisian College of Dermatologists and the Cancer Council Australia, 2005. Available at: http://www.dermcoll.asn.au/skin/ccrisksandbenefitsMarch8.pdf. Accessed March 8, 2005.

        • Boucher B.J.
        Sunlight “D”ilemma.
        Lancet. 2001; 357: 961
        • Calvo M.S.
        • Whiting S.J.
        • Barton C.N.
        Vitamin D intake: a global perspective of current status.
        J Nutr. 2005; 135: 310-316
        • Utiger R.D.
        The need for more vitamin D.
        N Engl J Med. 1998; 338: 828-829
        • Holick M.F.
        Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness.
        Lancet. 2001; 357: 4-6
        • Moore C.
        • Murphy M.M.
        • Keast D.R.
        • Holick M.F.
        Vitamin D intake in the United States.
        J Am Diet Assoc. 2004; 104: 980-983
      4. 1997 RDA Standing Committee on the Scientific Evaluation of Dietary Reference Intakes.
        Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, DC1997 (pp. 250-87)
        • Holick M.F.
        In reply to “The physiology and treatment of vitamin D deficiency.”.
        Mayo Clin Proc. 2004; 79: 694-695
        • Holick M.F.
        • Matsuoka L.Y.
        • Wortsman J.
        Age, vitamin D, and solar ultraviolet.
        Lancet. 1989; 2: 1104-1105
        • Chen T.C.
        • Shao A.
        • Heath III, H.
        • Holick M.F.
        An update on the vitamin D content of fortified milk from the United States and Canada.
        N Engl J Med. 1993; 329: 1507
        • Holick M.F.
        • Shao Q.
        • Liu W.W.
        • Chen T.C.
        The vitamin D content of fortified milk and infant formula.
        N Engl J Med. 1992; 326: 1178-1181
        • Davie M.W.
        • Lawson D.E.
        • Emberson C.
        • Barnes J.L.
        • Roberts G.E.
        • Barnes N.D.
        Vitamin D from skin: contribution to vitamin D status compared with oral vitamin D in normal and anticonvulsant-treated subjects.
        Clin Sci (Colch). 1982; 63: 461-472
        • Marks R.
        • Foley P.A.
        • Jolley D.
        • Knight K.R.
        • Harrison J.
        • Thompson S.C.
        The effect of regular sunscreen use on vitamin D levels in an Australian population: results of a randomized controlled trial.
        Arch Dermatol. 1995; 131: 415-421
        • Pinnell S.R.
        Cutaneous photodamage, oxidative stress, and topical antioxidant protection.
        J Am Acad Dermatol. 2003; 48: 1-22
        • Adams J.S.
        • Lee G.
        Gains in bone mineral density with resolution of vitamin D intoxication.
        Ann Intern Med. 1997; 127: 203-206
        • Vieth R.
        • Chan P.C.
        • MacFarlane G.D.
        Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level.
        Am J Clin Nutr. 2001; 73: 288-294
        • de Gruijl F.R.
        Skin cancer and solar UV radiation.
        Eur J Cancer. 1999; 35: 2003-2009
        • Matsuoka L.Y.
        • Ide L.
        • Wortsman J.
        • MacLaughlin J.A.
        • Holick M.F.
        Sunscreens suppress cutaneous vitamin D3 synthesis.
        J Clin Endocrinol Metab. 1987; 64: 1165-1168
        • Parrish J.A.
        • Jaenicke K.F.
        • Anderson R.R.
        Erythema and melanogenesis action spectra of normal human skin.
        Photochem Photobiol. 1982; 36: 187-191
        • Gilchrest B.A.
        Sunscreens–a public health opportunity.
        N Engl J Med. 1993; 329: 1193-1194
        • Pfahlberg A.
        • Kolmel K.F.
        • Gefeller O.
        Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma.
        Br J Dermatol. 2001; 144: 471-475
        • Hunter D.J.
        • Colditz G.A.
        • Stampfer M.J.
        • Rosner B.
        • Willett W.C.
        • Speizer F.E.
        Risk factors for basal cell carcinoma in a prospective cohort of women.
        Ann Epidemiol. 1990; 1: 13-23
        • Kennedy C.
        • Bajdik C.D.
        • Willemze R.
        • De Gruijl F.R.
        • Bouwes Bavinck J.N.
        The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer.
        J Invest Dermatol. 2003; 120: 1087-1093
        • van Dam R.M.
        • Huang Z.
        • Rimm E.B.
        • Weinstock M.A.
        • Spiegelman D.
        • Colditz G.A.
        • et al.
        Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study.
        Am J Epidemiol. 1999; 150: 459-468
        • Bell N.H.
        Vitamin D metabolism, aging, and bone loss.
        J Clin Endocrinol Metab. 1995; 80: 1051
        • Need A.G.
        • Morris H.A.
        • Horowitz M.
        • Nordin C.
        Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D.
        Am J Clin Nutr. 1993; 58: 882-885
        • Chuck A.
        • Todd J.
        • Diffey B.
        Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study.
        Photodermatol Photoimmunol Photomed. 2001; 17: 168-171
        • Reid I.R.
        • Gallagher D.J.
        • Bosworth J.
        Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure.
        Age Ageing. 1986; 15: 35-40
        • Clemens T.L.
        • Adams J.S.
        • Henderson S.L.
        • Holick M.F.
        Increased skin pigment reduces the capacity of skin to synthesize vitamin D3.
        Lancet. 1982; 1: 74-76
        • Kreiter S.R.
        • Schwartz R.P.
        • Kirkman Jr., H.N.
        • Charlton P.A.
        • Calikoglu A.S.
        • Davenport M.L.
        Nutritional rickets in African American breast-fed infants.
        J Pediatr. 2000; 137: 153-157
        • Gartner L.M.
        • Greer F.R.
        Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake.
        Pediatrics. 2003; 111: 908-910
        • Agarwal K.S.
        • Mughal M.Z.
        • Upadhyay P.
        • Berry J.L.
        • Mawer E.B.
        • Puliyel J.M.
        The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India.
        Arch Dis Child. 2002; 87: 111-113
      5. World Health Organization. Sunbeds, tanning and UV exposure. Available at: http://www.who.int/mediacentre/factsheets/fs287/en/. Accessed March 2005.

        • Levy S.
        Sunscreens.
        in: Wolverton S. Comprehensive dermatologic drug therapy. WB Saunders Co, Philadelphia2001: 632-646
        • Bech-Thomsen N.
        • Wulf H.C.
        Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation.
        Photodermatol Photoimmunol Photomed. 1992; 9: 242-244
        • Matsuoka L.Y.
        • Wortsman J.
        • Hanifan N.
        • Holick M.F.
        Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: a preliminary study.
        Arch Dermatol. 1988; 124: 1802-1804
        • Farrerons J.
        • Barnadas M.
        • Rodriguez J.
        • Renau A.
        • Yoldi B.
        • Lopez-Navidad A.
        • et al.
        Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers.
        Br J Dermatol. 1998; 139: 422-427
        • Sollitto R.B.
        • Kraemer K.H.
        • DiGiovanna J.J.
        Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum.
        J Am Acad Dermatol. 1997; 37: 942-947
        • Webb A.R.
        • Pilbeam C.
        • Hanafin N.
        • Holick M.F.
        An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston.
        Am J Clin Nutr. 1990; 51: 1075-1081
        • Krause R.
        • Buhring M.
        • Hopfenmuller W.
        • Holick M.F.
        • Sharma A.M.
        Ultraviolet B and blood pressure.
        Lancet. 1998; 352: 709-710
        • Munger K.L.
        • Zhang S.M.
        • O'Reilly E.
        • Hernan M.A.
        • Olek M.J.
        • Willett W.C.
        • Ascherio A.
        Vitamin D intake and incidence of multiple sclerosis.
        Neurology. 2004; 62: 60-65